Literature DB >> 17098697

Coexistence of pernicious anemia and myasthenia gravis--a rare combination of autoimmune diseases in Taiwan.

Kuo-Hsuan Chang1, Rong-Kuo Lyu, Long-Sun Ro, Yih-Ru Wu, Chiung-Mei Chen.   

Abstract

About 5-10% of patients with myasthenia gravis concomitantly have other autoimmune diseases. However, the coexistence of myasthenia gravis and pernicious anemia is rare. Here, we report a 73-year-old Taiwanese woman who developed myasthenia gravis 5 months after the onset of pernicious anemia. Her myasthenic and pernicious anemia symptoms markedly improved after pyridostigmine, prednisolone and hydroxocobalamine treatment. It is important to recognize concurrence of myasthenia gravis and pernicious anemia in the same patient because the therapeutic results for both diseases are rewarding.

Entities:  

Mesh:

Year:  2006        PMID: 17098697     DOI: 10.1016/S0929-6646(09)60181-9

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  5 in total

Review 1.  Autoimmune atrophic gastritis: current perspectives.

Authors:  Artem Minalyan; Jihane N Benhammou; Aida Artashesyan; Michael S Lewis; Joseph R Pisegna
Journal:  Clin Exp Gastroenterol       Date:  2017-02-07

Review 2.  Autoimmune diseases in autoimmune atrophic gastritis.

Authors:  Kryssia Isabel Rodriguez-Castro; Marilisa Franceschi; Chiara Miraglia; Michele Russo; Antonio Nouvenne; Gioacchino Leandro; Tiziana Meschi; Gian Luigi De' Angelis; Francesco Di Mario
Journal:  Acta Biomed       Date:  2018-12-17

Review 3.  Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency.

Authors:  Gianluca Esposito; Ludovica Dottori; Giulia Pivetta; Irene Ligato; Emanuele Dilaghi; Edith Lahner
Journal:  Nutrients       Date:  2022-04-17       Impact factor: 6.706

4.  Coexistence of Pernicious Anemia and Myasthenia Gravis Presenting As Dyspnea.

Authors:  Sara Khademolhosseini; Elspeth Springsted; Seyedmohammad Pourshahid; Badri Giri
Journal:  Cureus       Date:  2021-05-28

5.  Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario.

Authors:  Oriol Calvete; José Reyes; Hernán Valdés-Socin; Paloma Martin; Mónica Marazuela; Alicia Barroso; Javier Escalada; Antoni Castells; Raúl Torres-Ruiz; Sandra Rodríguez-Perales; María Currás-Freixes; Javier Benítez
Journal:  Cells       Date:  2021-12-10       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.